| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4069895a5bad4014e19777722c5be042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_960bcda6702b2939237639ce1f885de5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b042a218f244d928f43ff19b1ec810ef |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-128 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0677
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N11-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 |
| filingDate |
1996-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87b87f08c57f4344510ff07b695b517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a138d1816461b1bbf943f2a26664184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9db26fcecc017f5b9a8dadb394f8ae3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_738857fa937d170ac5044c193e22d04b |
| publicationDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2216359-A1 |
| titleOfInvention |
Pharmaceutical microencapsulation |
| abstract |
A method of producing a microencapsulated pharmaceutical formulation is disclose d comprising causing a dye to be attached to the surface of pharmaceutical particles or particle clusters and applying a source o f radiant energy to the dye in the presence of a liquid polymeric or polymerisable material so as to cause the material to cross-link, producing a conformal layer of cross-linked polymer on the particulate surfaces. Preferably, the polymer provides an immuno-protective layer around the particles. while allowing therapeutic components to exit the microcapsules. Microencapsulated pharmaceutical formulations and their medi cal use are also disclosed, especially for the treatment of diabetes by encapsulating insulin secreting cells. |
| priorityDate |
1995-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |